Related Articles
FDA Approves Trastuzumab Biosimilar Trastuzumab-strf
The FDA has approved trastuzumab-strf (Hercessi), a biosimilar to trastuzumab (Herceptin), for the treatment of HER2-overexpressing breast cancer and gastric or gastroesophageal junction adenocarcinom…
AUA, ASCO, and SUO Publish 2024 Amendment to Nonmetastatic Muscle-Invasive Bladder Cancer Guidelines
The American Urological Association (AUA), in partnership with ASCO and the Society of Urologic Oncology (SUO), has issued a 2024 clinical practice guideline amendment for…
FDA Approves Tisotumab Vedotin-tftv for Recurrent or Metastatic Cervical Cancer
On April 29, the FDA granted traditional approval to tisotumab vedotin-tftv (Tivdak) for patients with recurrent or metastatic cervical cancer whose disease progressed on or…
Financial Hardships Caused by Cancer Are Long-Lasting for Many Working-Age Adults
With the high out-of-pocket costs for cancer care, nearly 60% of working-age cancer survivors report experiencing at least one type of financial hardship, including being…
MRI-Guided Duration of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
In a Dutch phase II study (TRAIN-3), researchers found that MRI detected complete radiologic response after only three cycles of neoadjuvant chemotherapy in many patients…
Wendy Vogel, MSN, FNP, AOCNP, FAPO, on the Evolving Role of Advanced Practice Providers in Oncology Care
Wendy Vogel, MSN, FNP, AOCNP, FAPO, of the Advanced Practitioner Society for Hematology and Oncology, summarizes a panel discussion in which she took part, on…
Combined ICI and VEGF Inhibitor Trials in Cancer: Cardiovascular Eligibility Criteria and Adverse Event Reporting
A scoping review analyzed the degree to which published phase II to IV trials of combination immune checkpoint inhibitor (ICI) and VEGF inhibitor treatment of…
Breast Cancer Survivors: Relationship Satisfaction and Emotional and Physical Well-Being
Breast cancer survivors’ emotional and physical health may be influenced by the relationship with their partners.
Lack of Research Focused on Older Adults With Cancer May Be Contributing to Disparities in Care
Investigators have found that the current body of research may inadequately address the intersection of aging, health disparities, and cancer outcomes among older patients.
Douglas B. Johnson, MD, MSCI, on Cutaneous Melanoma: Treatment Updates
Douglas B. Johnson, MD, MSCI, of Vanderbilt-Ingram Cancer Center, discusses updated guidelines on the use of neoadjuvant therapy, as well as first- and later-line systemic…